Copyright 2017 American Medical Association. All Rights Reserved.
A new stent system that could help patients avoid a second invasive procedure to treat severe ureteral obstruction has received FDA approval, according to the device’s manufacturer, BrightWater Medical Inc, Mountain View, California.
Patients with obstructions that prevent urine drainage from the kidneys to the bladder face potential pain, blood in the urine, repeated urinary tract infections, nausea and vomiting, or fever and chills. Severe ureteral obstruction can lead to irreversible kidney damage and may require emergency treatment.
Voelker R. Relief for Ureteral Obstruction. JAMA. 2017;317(3):247. doi:10.1001/jama.2016.19759
Customize your JAMA Network experience by selecting one or more topics from the list below.